Xarelto Pharmaceutical Claims

If you or a family member were prescribed Xarelto and have experienced negative side-effects, seek medical attention immediately. The FDA has warned of adverse effects this drug will cause. Let our legal team provide a no-cost evaluation of your case, and help you navigate the pharmaceutical claim process.

Information

Did you or a loved one experience uncontrollable bleeding after taking Xarelto? We will review your case at no charge.

Xarelto is an anticoagulant (blood thinner) manufactured by Janssen Pharmaceuticals and co-marketed by Bayer Healthcare. Xarelto is most commonly used to treat: blood clots in people with atrial fibrillation and heart rhythm disorders, deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of blood clots for those undergoing certain surgeries.

Approved in July 2011, Xarelto is one of the newest and most heavily marketed blood thinners on the market, recently reaching blockbuster status – current sales are estimated around $1 billion worldwide. This drug was marketed as a blood thinner that didn’t require the routine monitoring as other blood thinners required. As a blood thinner, Xarelto carries inherent risks of uncontrollable bleeding. However, unlike its’ predecessor Warfarin, Xarelto does not have an approved antidote or reversal agent, meaning medical professionals may not be able to reverse bleeding. This is in contrast to other blood thinners, which may be reversed with the antidote. Now experts are claiming monitoring could have spared serious injury or death.

Symptoms and Side-Effects

With inadequate product warnings and lack of reversal agent, Xarelto poses a high threat level to patients. Lawsuits are being filed across the country against the manufacturers of Xarelto for serious injuries or death arising from the use of this drug, claiming the medication produces an unreasonably high risk.

The most serious potential side effect, complication, and risk caused by Xarelto is severe internal bleeding that can result in serious injury or death.

These injuries include:

News

Plaintiffs across the country have filed claims against Johnson & Johnson and Bayer for injuries related to Xarelto, alleging the manufacturer failed to warn of adverse side effects. Many patients who took Xarelto were unaware of the potential life-threatening complications or the absence of a reliable reversal agent.

Under U.S. law, drug manufacturers are obligated to disclose important safety information about their products. Recently, the FDA has required increasingly specific warning labels on Xarelto over concerns about the drugs’ safety.

Review FDA Safety Alert

After a number of Xarelto lawsuits were filed in federal court, the U.S. Judicial Panel on Multidistrict Litigation granted a petition to consolidate Xarelto lawsuits. This petition to consolidate was granted in December 2014 and all cases filed in federal court were transferred to the MDL before U.S. District Judge Eldon E. Fallon in the Eastern District of Louisiana. Judge Fallon has a great deal of MDL experience in complex product liability claims. Multi-district litigation (MDL) is a federal legal procedure designed to speed the process of handling complex product liability claims and streamline discovery in order to preserve efficiency. Under the MDL, plaintiffs and defendants are in one court, which allows all claims to follow the same judicial process and eliminates duplicative discovery and eliminates contradicting rulings.

As to date, no Xarelto lawsuits have gone to trial or have been settled. This litigation is in its early stages and can take years to be resolved. As with any product liability litigation, there are strict statutes of limitation and you have a limited amount of time to file a claim and protect your legal rights.

Injured?